Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cyclophosphamide Toxicity”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Early research (Phase 1)Study completedNCT00001676
What this trial is testing

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

Who this might be right for
GlomerulonephritisLupus NephritisSystemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Not applicableStudy completedNCT05886335
What this trial is testing

Influence of Timing PTCy in AlloSCT

Who this might be right for
Cyclophosphamide ToxicityAllogenic Haematopoetic Transplantation
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 180
Not applicableUnknownNCT04654195
What this trial is testing

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Who this might be right for
Breast Cancer Patients
Damanhour University 100
Testing effectiveness (Phase 2)Study completedNCT00727441
What this trial is testing

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87
Testing effectiveness (Phase 2)UnknownNCT00882323
What this trial is testing

Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)

Who this might be right for
Aplastic Anemia
The Korean Society of Pediatric Hematology Oncology 33
Large-scale testing (Phase 3)Study completedNCT02214381
What this trial is testing

A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response

Who this might be right for
Early Primary Breast Cancer
Women's Cancer Study Group GmbH 80
Post-approval studies (Phase 4)UnknownNCT05302336
What this trial is testing

AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Toxicity
Second Affiliated Hospital, Zhejiang University, School of Medicine 402
Testing effectiveness (Phase 2)Ended earlyNCT01301040
What this trial is testing

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Who this might be right for
Breast Cancer
Jules Bordet Institute 2
Not applicableStudy completedNCT00001473
What this trial is testing

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

Who this might be right for
VasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT00941720
What this trial is testing

Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Case Comprehensive Cancer Center 71
Not applicableStudy completedNCT03908528
What this trial is testing

Alpha-Lipoic Acid in Breast Cancer Patients

Who this might be right for
Breast CancerChemotherapeutic Toxicity
Damanhour University 64
Testing effectiveness (Phase 2)Study completedNCT06186700
What this trial is testing

Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer

Who this might be right for
Breast Cancer FemaleBreast Cancer PatientsNeoadjuvant Therapy+2 more
Mansoura University 100
Testing effectiveness (Phase 2)UnknownNCT00382694
What this trial is testing

Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Nordic Myeloma Study Group 80
Not applicableStudy completedNCT01779882
What this trial is testing

Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT

Who this might be right for
Myeloid LeukemiaPrecursor Myeloid NeoplasmsLymphoid Neoplasms
University Hospital, Basel, Switzerland 72
Not applicableLooking for participantsNCT03555851
What this trial is testing

Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

Who this might be right for
Leukemia, Not Otherwise SpecifiedLeukemia, Other
Wake Forest University Health Sciences 120
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00003068
What this trial is testing

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/Organ
University of Arizona 30
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Early research (Phase 1)Study completedNCT01435499
What this trial is testing

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

Who this might be right for
Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Next Page